Educating Immune Cells. Eliminating Cancer. MANA is working to transform the role of cell therapies in the treatment of a broad range of liquid and solid tumors by making them more effective, safer, and more accessible.
Employees: 11-50
Total raised: $35M
Founded date: 2018
Investors 2
| Date | Name | Website |
| - | Lightchain... | lightchain... |
| - | Cobro Vent... | cobroventu... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.01.2021 | Series A | $35M | - |
Mentions in press and media 4
| Date | Title | Description |
| 08.01.2021 | Startup Funding News for the Day – Medtech sector | These are some US-based Medtech startups that raised funding today- |
| 08.01.2021 | MANA Therapeutics Launches with $35 Million Series A Financing | WALTHAM, Mass.--(BUSINESS WIRE)--MANA Therapeutics, a clinical-stage company creating nonengineered, off-the-shelf allogeneic cell therapies that target multiple cancer antigens, today announced a $35 million Series A financing. The financi... |
| 08.01.2021 | Mana Therapeutics Raises $35M Series A Financing | Mana Therapeutics, a Waltham, Mass.-based clinical-stage company creating nonengineered, off-the-shelf allogeneic cell therapies that target multiple cancer antigens, raised $35m in Series A financing. The round was was led by Cobro Venture... |
| 08.01.2021 | MANA Therapeutics Launches with $35M Series A | ARLINGTON, VA, MANA Therapeutics announced a $35 million Series A financing led by Cobro Ventures and Lightchain Capital. >> Click here for more funding data on MANA Therapeutics >> To export MANA Therapeutics funding data t... |